Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants

Transplantation

Volumn 64, Issue 8, 1997, Pages 1107-1111

  Yamagami, Satoru ^a   Kawashima, Hidetoshi ^a   Tsuru, Tadahiko ^c   Yamagami, Hiroko ^b   Kayagaki, Nobuhiko ^d   Yagita, Hideo ^d   Okumura, Ko ^d   Gregerson, Dale S ^e  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC RESTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CELL INFILTRATION; CORNEA TRANSPLANTATION; GRAFT REJECTION; HYPOTHESIS; IMMUNE RESPONSE; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CORNEAL OPACITY; CORNEAL TRANSPLANTATION; DRUG INTERACTIONS; FAS LIGAND PROTEIN; GRAFT REJECTION; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 0030716516     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710270-00004     Document Type: Article

References (25)

1. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in T cell lineage. J Immunol 1995; 154: 3806.
2. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Golstein P. TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med 1995; 181: 781.
3. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor. Cell 1993; 75: 1169.
4. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449.
5. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76: 959.
6. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
7. Griffith TS, Brunner T, Fletcher S, Green D, Ferguson T. Fas-ligand induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189.
8. Griffith TS, Yu X, Herdon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996; 5: 7.
9. Price FW, Whitson WE, Marks RG. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology 1991; 98: 322.
10. Boisjoly HM, Tourigney R, Bazin R, et al. Risk factors of corneal graft failure. Ophthalmology 1993; 100: 1728.
11. Yamagami S, Suzuki Y, Tsuru T. Risk factors for graft failure in penetrating keratoplasty. Acta Ophthalmol Scand 1996; 74: 584.
12. Stuart PM, Griffith TS, Usui N, Pepose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997; 99: 396.
13. Takahashi T, Tanaka M, Brannan CI, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76: 969.
14. Kayagaki N, Yamaguchi N, Nagao F, et al. Polymorphism of murine Fas ligand that affects the biological activity. Proc Natl Acad Sci USA 1997; 94: 3914.
15. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992; 54: 694.
16. Yamagami S, Tsuru T, Isobe M, Obata H, Suzuki J. The role of cell adhesion molecules in allograft rejection after penetrating keratoplasty in mice, clinical and immunohistochemical study. Graefe's Arch Clin Exp Ophthalmol 1996; 234: 382.
17. Garrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493.
18. Ren H, Wilson G. Apoptosis in the corneal epithelium. Invest Ophthalmol Vis Sci 1996; 37: 1017.
19. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci 1995; 36: 1530.
20. Sonoda Y, Sano Y, Ksander B, Streilein JY. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 1995; 36: 427.
21. Kagi D, Vignaux F, Ledermann B, et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265: 528.
22. Streilein JW. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol 1993; 5: 428.
23. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol 1994; 153: 1982.
24. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991; 32: 2201.
25. Lau HT, Yu M, Fontana A, Stoeckert CJ. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996; 273: 109.